HK Stock Market Move | Melco International Development (00200) rose more than 3% with a 174% year-on-year increase in net revenue for the third quarter of Studio City.

09:31 07/11/2025

Sands China Ltd. (00200) rose by over 3%, as of the time of writing, it increased by 3.31% to HKD 5, with a turnover of HKD 6.3717 million.

MELCO INT'L DEV (00200) rose more than 3%, as of the deadline, it rose 3.31% to HK$5, with a turnover of HK$6.3717 million. On the news front, on November 6, MELCO INT'L DEV announced that its listed subsidiary, Melco Resorts and Entertainment Limited, had recorded total operating revenue of US$1.31 billion for the third quarter of 2025, an increase of approximately 11% year-on-year. The increase in total operating revenue was mainly attributed to improvements in both gaming and non-gaming operations. Melco Resorts and Entertainment's attributable net income was US$74.7 million, a 174% increase year-on-year; earnings per American Depositary Share were US$0.19.

SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.

SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.